登录

HealAI Snares ¥10M in Series A Round

Mailman 2020-02-20 18:11

万灵
http://www.healai.com
企业数据由 动脉橙 提供支持
精神科人工智能辅助诊断系统提供商 | A轮 | 运营中
中国-北京
2020-02-19
融资金额:近千万人民币
中山贝森医疗产业投资
查看

According to 36Kr.com, HealAI has completed its series A financing of tens of million yuan with participation from Zhongshan Beisen Medical Industry Investment. Proceeds of this round will be used for clinical trials of HealAI's products, and the follow-up registration and approval.


HealAI closed its ¥6.45 million angel round of financing in November 2016, led by Skyview Fund and XY Venture Capital, with participation from PreIPO. After that, it completed ¥15 million Pre-A round of financing invested by GP Healthcare Capital in 2018.


Founded in 2016, HealAI uses artificial intelligence (AI) to help patients with mental disorders. The company provides diagnosis and treatment services based on AI screening tools. It has independently developed the "HealAI Cloud" system, which can conduct pre-diagnosis and screening for mental disorders, and doctors can make specific consultations based on the results. Meanwhile, the system can also estimate prognosis and provide treatment plans and medication advice.


Mental disorders are different from other diseases with clear biological markers for diagnosis, they are mainly diagnosed and treated through questionnaire and interview. The whole process is time-consuming and relies on doctors' experience. The key to the treatment of mental disorders is how to improve the efficiency and accuracy of clinical diagnosis. JiJun, the founder of HealAI, said that AI is an important breakthrough, AI tools can be used for early screening.


HealAI's goal is not only the initial screening, but also including auxiliary diagnosis, and even diagnosis and treatment. The company has a clear product matrix, including products of depression auxiliary diagnosis, bipolar disorder auxiliary diagnosis, near-infrared auxiliary diagnosis, psychological iCBT intervention, and so on, covering both adults and children from screening to intervention.


>>>>

About Zhongshan Beisen Medical Industry Investment


Founded in 2017 with registered capital of 260 million yuan, Zhongshan Beisen Medical Industry Investment is a Beijing-based financial company under the management of Zhongshan Health Technology Park Development Co., Ltd. and some other companies.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。
推荐阅读

国务院办公厅印发《促进创业投资高质量发展的若干政策措施》

中证网 2024-06-19 19:19

JOP:儿童年龄与用药错误风险之间的关系

MedSci 2024-06-19 19:15

中信银行南京分行落地江苏省首笔绿色科技创新再贷款业务

中证网 2024-06-19 19:07

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

相关公司
查看更多

万灵

精神科人工智能辅助诊断系统提供商

立即沟通

中山贝森医疗产业投资

医疗领域投资机构

立即沟通
产业链接
查看更多